Clinical Trials
3 trialsNCT03775265 2026-05-04
Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT07097142 2026-05-04
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NRG Oncology
Phase 3 Recruiting
NCT00330499 2017-07-12
Efficacy Study of Adding Chemotherapy to Radiotherapy for Treating Bladder Cancer.
Trans Tasman Radiation Oncology Group
Phase 3 Completed